Literature DB >> 25108896

Prognostic factors of remission in myasthenia gravis after thymectomy.

Zhifeng Mao1, Xueqiang Hu2, Zhengqi Lu1, Maree L Hackett3.   

Abstract

Thymectomy has become an increasingly popular procedure for myasthenia gravis. Knowledge of factors associated with a good outcome (remission) or those most likely to benefit from surgery can help clinical decision-making. A systematic review search was conducted in Medline and Embase for English language studies from 1985 through to February 2014. Studies which evaluated variables associated with, or predictive of, remission in adult (≥18 years) myasthenic patients after thymectomy and using multivariable regression models were included. Statistical pooling was not appropriate due to methodological heterogeneity. From 128 potentially relevant studies, 18 reports of 19 studies met the inclusion criteria. Preoperative mild disease classification (i.e. studies reported this variable as Osserman classification 1, 2A or MGFA I-II) showed the most consistent association with remission. Evidence for several other prognostic factors was inconclusive, or no evidence was found. Gender, age and absence of thymoma (or hyperplasia) were not associated with remission following thymectomy. Patients with mild disease preoperatively may have a better chance of remission of MG after thymectomy.
© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Myasthenia gravis; Outcomes; Systematic review; Thymectomy

Mesh:

Year:  2014        PMID: 25108896     DOI: 10.1093/ejcts/ezu309

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

Review 1.  Thymectomy in Myasthenia Gravis.

Authors:  Yener Aydin; Ali Bilal Ulas; Vahit Mutlu; Abdurrahim Colak; Atilla Eroglu
Journal:  Eurasian J Med       Date:  2017-02

2.  Outcomes after Thymectomy in Patients with Thymomatous Myasthenia Gravis.

Authors:  Sani Rabiou; Moussa Toudou-Daouda; Marwane Lakranbi; Ibrahim Issoufou; Yassine Ouadnouni; Mohamed Smahi
Journal:  J Neurosci Rural Pract       Date:  2022-03-09

Review 3.  Thymectomy in Myasthenia Gravis: A Narrative Review.

Authors:  Danah Aljaafari; Noman Ishaque
Journal:  Saudi J Med Med Sci       Date:  2022-04-29

4.  Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database.

Authors:  Sukhmani K Padda; Xiaopan Yao; Alberto Antonicelli; Jonathan W Riess; Yue Shang; Joseph B Shrager; Robert Korst; Frank Detterbeck; James Huang; Bryan M Burt; Heather A Wakelee; Sunil S Badve
Journal:  J Thorac Oncol       Date:  2017-11-27       Impact factor: 15.609

5.  Short-term and sustained clinical response following thymectomy in patients with myasthenia gravis.

Authors:  Jakob Rath; Manuela Taborsky; Bernhard Moser; Gudrun Zulehner; Rosa Weng; Martin Krenn; Hakan Cetin; José Ramon Matilla; Leonhard Müllauer; Fritz Zimprich
Journal:  Eur J Neurol       Date:  2022-04-30       Impact factor: 6.288

6.  Clinical Profile and Outcome of Postthymectomy versus Non-Thymectomy Myasthenia Gravis Patients in the Philippine General Hospital: A 6-Year Retrospective Study.

Authors:  Ranhel C De Roxas; Marjorie Anne C Bagnas; Jobelle Joyce Anne R Baldonado; Jonathan P Rivera; Artemio A Roxas
Journal:  Front Neurol       Date:  2016-06-21       Impact factor: 4.003

7.  Ectopic germinal centers in the thymus accurately predict prognosis of myasthenia gravis after thymectomy.

Authors:  Johannes Dunkel; Anni Tuulasvaara; Joona Sarkkinen; Antti Huuskonen; Sari Atula; Eliisa Kekäläinen; Sini M Laakso
Journal:  Mod Pathol       Date:  2022-03-25       Impact factor: 8.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.